https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/dubowitz-neuromuscular-centre-confirmed-centre-paediatric-clinical-and-research-excellence/
Dubowitz Neuromuscular Centre confirmed as Centre of Paediatric Clinical and Research Excellence
22 Mar 2016, 3:37 p.m.
The Dubowitz Neuromuscular Centre has been confirmed as a Centre of Paediatric Clinical and Research Excellence by Muscular Dystrophy UK. The centre, based at Great Ormond Street Hospital and the UCL Institute of Child Health (ICH), is one of only ten Centres of Excellence and is the sole Paediatric Centre of Clinical and Research Excellence. This award recognises centres with outstanding levels of specialist care for people living with muscle wasting conditions.
The Dubowitz Neuromuscular Centre is a leading clinical- and research centre specialising in neuromuscular disorders affecting children. The centre provides clinical assessments, diagnostic services, and advice on treatment and rehabilitation alongside clinical trials and basic research focusing on causes of neuromuscular diseases in childhood and identifying new therapeutic interventions. The status was awarded following a national audit carried out by Muscular Dystrophy UK, aimed at ensuring that high-quality care is provided to patients with muscle-wasting conditions.
Great Ormond Street BRC Theme Lead, Professor Francesco Muntoni, is Head of the Dubowitz Neuromuscular Centre, and also leads the Novel Therapies for Translation in Childhood Diseases and the Developmental Neuroscience Programme at the ICH. He is co-director of the MRC Centre for Neuromuscular Diseases at UCL.
Toddler doing well after receiving newest gene therapy available on NHS
A toddler with a life-limiting and life-threatening rare disease is the youngest to be treated with the newest gene therapy available on the NHS at GOSH.
Genes may help to predict which children will respond well to arthritis treatment
A team of researchers at Great Ormond Street Hospital (GOSH) and University College London (UCL) have identified a set of genes that could be used to help doctors predict which children will respond well to treatment for juvenile idiopathic arthritis.
Making it easier to invest in frontline care
GOSH and UCL have signed a landmark agreement to simplify the commercialisation of any joint research and innovation and ensure any financial proceeds are shared equally.
Patients and public help create multilingual resources for expectant parents
A group of clinicians and researchers at GOSH have developed information about a test offered in pregnancy called prenatal sequencing in the UK’s 12 most common languages.